Tag: Alzheimer’s disease
R.I. Alzheimer’s expert among group that released recommendations on blood tests
PROVIDENCE – A Rhode Island doctor is among a group of worldwide Alzheimer’s disease experts who released recommendations in late July on the use...
Butler psychiatry resident honored by National Institute of Mental Health
PROVIDENCE – A Butler Hospital psychiatry resident and researcher has been selected for a prestigious national honor.
Dr. Matthew David Howe is the 2022 recipient...
Salloway to step down as Butler’s Memory and Aging Program director
PROVIDENCE – Butler Hospital’s Dr. Stephen Salloway, a neurologist who has earned international recognition for his research on treatments for Alzheimer’s disease, will step...
Study co-authored by URI professor may link faulty brain drainage systems...
SOUTH KINGSTOWN – Researchers from the University of Rhode Island, working with research teams from the Yale School of Medicine and Stony Brook University,...
NIH provides $16M grant to Alzheimer’s research group led by Brown...
PROVIDENCE – The director of Brown University’s Center on Biology of Aging will lead a team of researchers from multiple universities to look into...
Five Questions With: Peter Snyder
Peter Snyder | Deputy executive editor, Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association; University of Rhode Island vice president for research and economic development
1. You...
$904K federal grant to support CareLink’s Alzheimer’s program
EAST PROVIDENCE – New supports and treatment programs for Rhode Islanders living with Alzheimer’s disease and their caregivers are soon to be developed thanks...
R.I experts to speak at virtual Alzheimer’s conference
PROVIDENCE – A virtual conference, free and open to all Rhode Islanders, will be hosted by the Alzheimer’s Foundation of America on Dec. 7.
The...
R.I. Alzheimer’s expert among group offering guidance on groundbreaking treatment
PROVIDENCE – A Rhode Island doctor was among a group of leading Alzheimer’s disease experts who presented detailed guidance last week on the use...
FDA approves much-debated Alzheimer’s drug panned by experts
WASHINGTON (AP) – Government health officials on Monday approved the first new drug for Alzheimer’s disease in nearly 20 years, disregarding warnings from independent...
- Featured Event -
